研究报告 |
|
|
|
|
自噬抑制肿瘤坏死因子α诱导人胎盘胎儿来源间充质干细胞发生凋亡 * |
朱永朝1,**,陶金1,**,任萌萌2,熊燃3,何亚琴1,周瑜1,卢震辉1,杜勇1,杨芝红1,**() |
1 宁夏医科大学总医院 银川 750004 2 银川市妇幼保健院 银川 750001 3 深圳精准医疗科技有限公司 深圳 518000 |
|
Autophagy Protects Against Apoptosis of Human Placental Mesenchymal Stem Cells of Fetal Origin Induced by Tumor Necrosis Fator-α |
ZHU Yongzhao1,**,TAO Jin1,**,REN Meng-meng2,XIONG Ran3,HE Ya-qin1,ZHOU Yu1,LU Zhen-hui1,DU Yong1,YANG Zhi-hong1,**() |
1 Ningxia Medical University, Yinchuan 750004, China 2 Yinchuan Maternal and Children Health Care Hospital, Yinchuan 750001, China 3 Shenzhen Gentarget Biopharmaceutical Co., Ltd, Shenzhen 518000, China |
引用本文:
朱永朝,陶金,任萌萌,熊燃,何亚琴,周瑜,卢震辉,杜勇,杨芝红. 自噬抑制肿瘤坏死因子α诱导人胎盘胎儿来源间充质干细胞发生凋亡 *[J]. 中国生物工程杂志, 2019, 39(9): 62-67.
ZHU Yongzhao,TAO Jin,REN Meng-meng,XIONG Ran,HE Ya-qin,ZHOU Yu,LU Zhen-hui,DU Yong,YANG Zhi-hong. Autophagy Protects Against Apoptosis of Human Placental Mesenchymal Stem Cells of Fetal Origin Induced by Tumor Necrosis Fator-α. China Biotechnology, 2019, 39(9): 62-67.
链接本文:
https://manu60.magtech.com.cn/biotech/CN/10.13523/j.cb.20190909
或
https://manu60.magtech.com.cn/biotech/CN/Y2019/V39/I9/62
|
[1] |
Wang H Y, Li D R, Zhai Z C , et al. Characterization and therapeutic application of mesenchymal stem cells with neuromesodermal origin from human pluripotent stem cells. Theranostics, 2019,9(6):1683-1697.
|
[2] |
Jin Q Q, Yuan K Y, Lin W Z , et al. Comparative characterization of mesenchymal stem cells from human dental pulp and adipose tissue for bone regeneration potential. Artif Cells Nanomed Biotechnol, 2019,47(1):1577-1584.
|
[3] |
Park Y K, Heo S J, Koak J Y , et al. Characterization and differentiation of circulating blood mesenchymal stem cells and the role of phosphatidylinositol 3-kinase in modulating the adhesion . Int J Stem Cells, 2019, 31; 12(2):265-278.
|
[4] |
Ayala-Cuellar A P, Kang J H, Jeung E B , et al. Roles of mesenchymal stem cells in tissue regeneration and immunomodulation. Biomol Ther (Seoul), 2019,27(1):25-33.
|
[5] |
Sriram G, Natu V P, Islam I , et al. Innate immune response of human embryonic stem cell-derived fibroblasts and mesenchymal stem cells to periodontopathogens. Stem Cells Int, 2016,2016:8905365.
|
[6] |
Johnson V, Webb T, Norman A , et al. Activated mesenchymal stem cells interact with antibiotics and host innate immune responses to control chronic bacterial infections. Sci Rep, 2017,7(1):9575.
|
[7] |
Lee S, Choi E, Cha M J , et al. Cell adhesion and long-term survival of transplanted mesenchymal stem cells: a prerequisite for cell therapy. Oxid Med Cell Longev, 2015,2015:632902.
|
[8] |
Ni X, Ou C, Guo J , et al. Lentiviral vector-mediated co-overexpression of VEGF and Bcl-2 improves mesenchymal stem cellsurvival and enhances paracrine effects in vitro. Int J Mol Med, 2017,40(2):418-426.
|
[9] |
Chang W, Song B W, Moon J Y , et al. Anti-death strategies against oxidative stress in grafted mesenchymal stem cells. Histol Histopathol, 2013,28(12):1529-1536.
|
[10] |
Dang S, Xu H, Xu C , et al. Autophagy regulates the therapeutic potential of mesenchymal stem cells in experimental autoimmune encephalomyelitis. Autophagy, 2014,10(7):1301-1315.
doi: 10.4161/auto.28771
|
[11] |
Dang S P, Yu Zh M, Zhang Ch Y , et al. Autophagy promotes apoptosis of mesenchymal stem cells under inflammatory microenvironment. Stem Cell Res Ther, 2015,6:247.
|
[12] |
Yang R, Ouyang Y, Li W , et al. Autophagy plays a protective role in tumor necrosis factor-α-induced apoptosis of bone marrow-derived mesenchymal stem cells. Stem Cells Dev, 2016,25(10):788-797.
|
[13] |
Wang L T, Ting C H, Yen M L , et al. Human mesenchymal stem cells (MSCs) for treatment towards immune- and inflammation-mediated diseases: review of current clinical trials. J Biomed Sci, 2016,23(1):76.
|
[14] |
Squillaro T, Peluso G, Galderisi U . Clinical trials with mesenchymal stem cells: an update. Cell Transplant, 2016,25(5):829-848.
|
[15] |
Haque N, Kasim N H, Rahman M T . Optimization of pre-transplantation conditions to enhance the efficacy of mesenchymal stem cells. Int J Biol Sci, 2015,11(3):324-334.
|
[16] |
Ma T, Wang X, Jiao Y , et al. Interleukin 17 (IL-17)-induced mesenchymal stem cells prolong the survival of alogeneic skin grafts. Ann Transplant, 2018,23:615-621.
|
[17] |
Cheng S, Li X, Jia Z , et al. The inflammatory cytokine TNF-α regulates the biological behavior of rat nucleus pulposus mesenchymal stem cells through the NF-κB signaling pathway in vitro. J Cell Biochem, 2019,120(8):13664-13679.
|
[18] |
Liu Z, Gao L, Wang P , et al. TNF-α induced the enhanced apoptosis of mesenchymal stem cells in ankylosing spondylitis by overexpressing TRAIL-R2. Stem Cells Int, 2017,2017:4521324.
|
[19] |
Li X, Du W, Ma F X , et al. High concentrations of TNF-α induce cell death during interactions between human umbilical cord mesenchymal stem cells and peripheral blood mononuclear cell. PLoS One, 2015,10(5):e0128647.
|
[20] |
Kim C, Park J M, Song Y , et al. HIF1α-mediated AIMP3 suppression delays stem cell aging via the induction of autophagy. Aging Cell, 2019,18(2):e12909.
|
[21] |
Hu C, Zhao L, Wu D , et al. Modulating autophagy in mesenchymal stem cells effectively protects against hypoxia- or ischemia-induced injury. Stem Cell Res Ther, 2019,10(1):120.
|
[22] |
Lee J H, Yoon Y M, Han Y S , et al. Melatonin protects mesenchymal stem cells from autophagy-mediated death under ischaemic er-stress conditions by increasing prion protein expression. Cell Prolif, 2019,52(2):e12545.
|
|
Viewed |
|
|
|
Full text
|
|
|
|
|
Abstract
|
|
|
|
|
Cited |
|
|
|
|
|
Shared |
|
|
|
|
|
Discussed |
|
|
|
|